Cargando…

Targeting the epigenome to treat neurodegenerative diseases or delay their onset: a perspective

Detalles Bibliográficos
Autor principal:	Coppedè, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820689/ https://www.ncbi.nlm.nih.gov/pubmed/35017429 http://dx.doi.org/10.4103/1673-5374.332145

Ejemplares similares

Can foods influence the onset and progress of neurodegenerative diseases?
por: Piemontese, Luca, et al.
Publicado: (2022)

Mitoepigenetics and Neurodegenerative Diseases
por: Coppedè, Fabio, et al.
Publicado: (2019)

The potential of epigenetic therapies in neurodegenerative diseases
por: Coppedè, Fabio
Publicado: (2014)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
por: Kwon, Somin, et al.
Publicado: (2020)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Mitochondrial DNA methylation and mitochondria-related epigenetics in neurodegeneration
por: Coppedè, Fabio
Publicado: (2023)

Targeting glial metabolism in neurodegenerative diseases: detail matters
por: Afridi, Ruqayya, et al.
Publicado: (2023)

Treating Neurodegenerative Disease with Antioxidants: Efficacy of the Bioactive Phenol Resveratrol and Mitochondrial-Targeted MitoQ and SkQ
por: Shinn, Lindsey J., et al.
Publicado: (2021)

Advance in the use of gold nanoparticles in the treatment of neurodegenerative diseases: new perspectives
por: Silveira, Gustavo de Bem, et al.
Publicado: (2021)

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021)

A perspective on age-related changes in cell environment and risk of neurodegenerative diseases
por: Liu, Alice Y.
Publicado: (2023)

A perspective on causality assessment in epigenetic research on neurodegenerative disorders
por: Koulousakis, Philippos, et al.
Publicado: (2022)

ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases
por: Lok, Hiu Chuen, et al.
Publicado: (2023)

Abnormal metal homeostasis as a common drug target to combat neurodegenerative diseases
por: Pretsch, Dagmar
Publicado: (2021)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Integrating epigenomics into pharmacogenomic studies
por: Zhang, Wei, et al.
Publicado: (2008)

Epigenomics and the structure of the living genome
por: Friedman, Nir, et al.
Publicado: (2015)

Can we treat neurodegenerative diseases by preventing an age-related decline in microRNA expression?
por: Vinnikov, Ilya A., et al.
Publicado: (2017)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Epigenomic reprogramming in peripheral nerve injury
por: Ma, Ki H., et al.
Publicado: (2016)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Tubulin glutamylation: a skeleton key for neurodegenerative diseases
por: van der Laan, Siem, et al.
Publicado: (2019)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Brain-derived neurotrophic factor in main neurodegenerative diseases
por: Camuso, Serena, et al.
Publicado: (2022)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
por: Vance, Jean E.
Publicado: (2012)

Role of myelin sheath energy metabolism in neurodegenerative diseases
por: Ravera, Silvia, et al.
Publicado: (2015)

Beneficial effects of date palm fruits on neurodegenerative diseases
por: Essa, Musthafa Mohamed, et al.
Publicado: (2016)

Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

A substrate scaffold for assessment of nerve regeneration and neurodegenerative diseases
por: Chen, Wei-Hsin, et al.
Publicado: (2015)

Whole-brain three-dimensional imaging for quantification of drug targets and treatment effects in mouse models of neurodegenerative diseases
por: Hansen, Henrik H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1vp54heusvrs78fdbrbobf7hun